Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis

Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibod...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Immunol
Asıl Yazarlar: Jacque, Emilie, Chottin, Claire, Laubreton, Daphné, Nogre, Michel, Ferret, Cécile, de Marcos, Sandrine, Baptista, Linda, Drajac, Carole, Mondon, Philippe, De Romeuf, Christophe, Rameix-Welti, Marie-Anne, Eléouët, Jean-François, Chtourou, Sami, Riffault, Sabine, Perret, Gérald, Descamps, Delphyne
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2021
Konular:
Immunology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8215542/
https://ncbi.nlm.nih.gov/pubmed/34163482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.683902
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller